+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UAE In Vitro Diagnostics Market, By Product (Instruments, Reagents, Software & Services), By Technology (Immunoassay, Hematology, Clinical Chemistry, Others), By Application, By End User, By Region, Competition Forecast & Opportunities, 2027

  • PDF Icon

    Report

  • 72 Pages
  • May 2022
  • Region: United Arab Emirates
  • TechSci Research
  • ID: 3105902
Free Webex Call
10% Free customization

The Market Growth Can be Attributed to the Rising Demand for the Diagnosis of Diseases and Rapidly Increasing Instances of Chronic and Infectious Diseases

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

UAE in vitro diagnostics market is projected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising demand for the diagnosis of diseases and rapidly increasing instances of chronic and infectious diseases. Besides, the rising mortality rate among the population due to the severity of diseases and the growing demand for personalized medicines are expected to drive the growth of the UAE in vitro diagnostics market in the coming years. Increasing pollution levels, unhealthy lifestyles, poor eating habits, and less physical activities are contributing to the rising incidences of lifestyle disorders. Increasing instances of diabetes, cancer, cardiovascular diseases, etc., have led to an increasing need for regular checkups and timely diagnostic tests, driving the growth of the UAE in the vitro diagnostics market. Increasing adoption of point of care testing and the growing prevalence of infectious and chronic diseases are driving the market growth.

Moreover, the development of miniaturized diagnostic systems and the growing application of disposable, inexpensive, portable, and easy-to-use medical devices are anticipated to aid the market growth. High accuracy and functionality offered by in vitro diagnostic instruments and rapid investments by public and private sectors for the development of diagnostic laboratories are likely to augment the industry expansion. Advancements in the testing kits, equipment, tools, etc., and evolution in the techniques like molecular sequencing, next-generation sequencing, etc., also support the growth of the market.

The UAE in vitro diagnostics market is segmented based on product, technology, application, end user, competitional landscape, and regional distribution. Based on product, the market is divided into instruments, reagents, and software & services. The reagents segment is expected to hold the largest share in the UAE in vitro diagnostics market due to the growing need for reliable, specific, and faster detection of chronic disorders.

Leading players in the UAE in vitro diagnostics market are Abbott Laboratories S.A., bioMérieux Middle East FZ LLC, Roche Diagnostics Middle East FZCO, Siemens Healthineers United Arab Emirates, QIAGEN Dubai, Becton Dickinson and Company UAE, Thermo Fischer Scientific UAE, Sysmex Middle East FZ-LLC, Danaher Corporation UAE, Bio-Rad Laboratories UAE, etc.

Years considered for this report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022E
  • Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of UAE in vitro diagnostics market from 2017 to 2021.
  • To estimate and forecast the market size of UAE in vitro diagnostics market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast UAE in vitro diagnostics market based on product, technology, application, end user, region, and company.
  • To identify dominant region or segment in the UAE in vitro diagnostics market.
  • To identify drivers and challenges for UAE in vitro diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in UAE in vitro diagnostics market.
  • To conduct pricing analysis in the UAE in vitro diagnostics market.
  • To identify and analyze the profile of leading players operating in UAE in vitro diagnostics market.
  • To identify key sustainable strategies adopted by market players UAE in vitro diagnostics market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of service providers across UAE. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include service providers, which could not be identified due to the limitations of secondary research. The publisher analyzed service providers and presence of all major players across UAE.

The publisher calculated the market size of UAE in vitro diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

  • In vitro diagnostic service providers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to in vitro diagnostics

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:


In this report, UAE in vitro diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

UAE In Vitro Diagnostics Market, By Product:

  • Instruments
  • Reagents
  • Software & Services

UAE In Vitro Diagnostics Market, By Technology:

  • Immunoassay
  • Hematology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Others

UAE In Vitro Diagnostics Market, By Application:

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Others

UAE In Vitro Diagnostics Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Centers & Laboratories
  • Others

UAE In Vitro Diagnostics Market, By Region:

  • Abu Dhabi
  • Dubai
  • Sharjah
  • Rest of UAE

Competitive Landscape


Company Profiles: Detailed analysis of the major companies present in UAE in vitro diagnostics market.

Available Customizations:


With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Service Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on UAE In Vitro Diagnostics Market5. Voice of Customer
6. UAE In Vitro Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Instruments, Reagents, Software & Services)
6.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
6.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
6.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
6.2.5. By Company (2021)
6.3. Market Map
7. UAE Immunoassay Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By End User
8. UAE Hematology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By End User
9. UAE Clinical Chemistry Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By End User
10. UAE Molecular Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By End User
11. UAE Microbiology Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments14. Policy & Regulatory Landscape15. UAE Economic Profile
16. Competitive Landscape
16.1. Abbott Laboratories S.A.
16.2. bioMérieux Middle East FZ LLC
16.3. Roche Diagnostics Middle East FZCO
16.4. Siemens Healthineers United Arab Emirates
16.5. QIAGEN Dubai
16.6. Becton Dickinson And Company UAE
16.7. Thermo Fischer Scientific UAE
16.8. Sysmex Middle East FZ-LLC
16.9. Danaher Corporation UAE
16.10. Bio-Rad Laboratories UAE
17. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories S.A.
  • bioMérieux Middle East FZ LLC
  • Roche Diagnostics Middle East FZCO
  • Siemens Healthineers United Arab Emirates
  • QIAGEN Dubai
  • Becton Dickinson And Company UAE
  • Thermo Fischer Scientific UAE
  • Sysmex Middle East FZ-LLC
  • Danaher Corporation UAE
  • Bio-Rad Laboratories UAE